Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Invested Capital (2020 - 2024)

RAPT Therapeutics' Invested Capital history spans 5 years, with the latest figure at $95.5 million for Q3 2024.

  • For Q3 2024, Invested Capital fell 44.73% year-over-year to $95.5 million; the TTM value through Sep 2024 reached $95.5 million, down 44.73%, while the annual FY2023 figure was $147.0 million, 40.03% down from the prior year.
  • Invested Capital for Q3 2024 was $95.5 million at RAPT Therapeutics, down from $109.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at $245.2 million in Q4 2022 and bottomed at $91.6 million in Q1 2021.
  • The 5-year median for Invested Capital is $167.8 million (2022), against an average of $160.3 million.
  • The largest annual shift saw Invested Capital surged 83.44% in 2021 before it crashed 45.3% in 2024.
  • A 5-year view of Invested Capital shows it stood at $104.2 million in 2020, then soared by 78.9% to $186.4 million in 2021, then soared by 31.54% to $245.2 million in 2022, then plummeted by 40.03% to $147.0 million in 2023, then crashed by 35.05% to $95.5 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Invested Capital are $95.5 million (Q3 2024), $109.2 million (Q2 2024), and $130.8 million (Q1 2024).